FIELD: organic chemistry, therapy, pharmacy. SUBSTANCE: invention relates to new potassium salts of derivatives of biphenylmethane: 2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl] -methyl-1,3,4-thiadiazoline-2-ylidene] -aminocarbonyl] -1-cyclopentene carboxylate mono- or dipotassium salts showing hypotensive activity. EFFECT: new compounds indicated above, hypotensive activity. 4 cl, 3 tbl, 2 ex
Authors
Dates
1999-11-20—Published
1995-02-08—Filed